{
    "title": "To amend the Public Health Service Act to provide for an NIH research strategic plan.",
    "content": "SECTION 1. NIH RESEARCH STRATEGIC PLAN.\n\n    Section 402 of the Public Health Service Act (42 U.S.C. 282) is \namended--\n            (1) in subsection (b), by amending paragraph (5) to read as \n        follows:\n            ``(5) shall ensure that scientifically based strategic \n        planning is implemented in support of research priorities as \n        determined by the agencies of the National Institutes of \n        Health, including through development, use, and updating of the \n        research strategic plan under subsection (m);''; and\n            (2) by adding at the end the following:\n    ``(m) Research Strategic Plan.--\n            ``(1) Five-year plans for biomedical research strategy.--\n                    ``(A) In general.--For each successive five-year \n                period beginning with the period of fiscal years 2016 \n                through 2020, the Director of NIH, in consultation with \n                the entities described in subparagraph (B), shall \n                develop and maintain a biomedical research strategic \n                plan.\n                    ``(B) Entities described.--The entities described \n                in this subparagraph are the directors of the national \n                research institutes and national centers, researchers, \n                patient advocacy groups, and industry leaders.\n            ``(2) Use of plan.--The Director of NIH and the directors \n        of the national research institutes and national centers shall \n        use the strategic plan--\n                    ``(A) to identify research opportunities; and\n                    ``(B) to develop individual strategic plans for the \n                research activities of each of the national research \n                institutes and national centers that--\n                            ``(i) have a common template; and\n                            ``(ii) identify strategic focus areas in \n                        which the resources of the national research \n                        institutes and national centers can best \n                        contribute to the goal of expanding knowledge \n                        on human health in the United States through \n                        biomedical research.\n            ``(3) Contents of plans.--\n                    ``(A) Strategic focus areas.--The strategic focus \n                areas identified pursuant to paragraph (2)(B) shall--\n                            ``(i) be identified in a manner that--\n                                    ``(I) considers the return on \n                                investment to the United States public \n                                through the investments of the National \n                                Institutes of Health in biomedical \n                                research; and\n                                    ``(II) contributes to expanding \n                                knowledge to improve the United States \n                                public's health through biomedical \n                                research; and\n                            ``(ii) include overarching and trans-\n                        National Institutes of Health strategic focus \n                        areas, to be known as Mission Priority Focus \n                        Areas, which best serve the goals of preventing \n                        or eliminating the burden of a disease or \n                        condition and scientifically merit enhanced and \n                        focused research over the next 5 years.\n                    ``(B) Rare and pediatric diseases and conditions.--\n                In developing and maintaining a strategic plan under \n                this subsection, the Director of NIH shall ensure that \n                rare and pediatric diseases and conditions remain a \n                priority.\n            ``(4) Initial plan.--Not later than 270 days after the date \n        of enactment of this subsection, the Director of NIH and the \n        directors of the national research institutes and national \n        centers shall--\n                    ``(A) complete the initial strategic plan required \n                by paragraphs (1) and (2); and\n                    ``(B) make such initial strategic plan publicly \n                available on the website of the National Institutes of \n                Health.\n            ``(5) Review; updates.--\n                    ``(A) Progress reviews.--Not less than annually, \n                the Director of NIH, in consultation with the directors \n                of the national research institutes and national \n                centers, shall conduct progress reviews for each \n                strategic focus area identified under paragraph (2)(B).\n                    ``(B) Updates.--Not later than the end of the 5-\n                year period covered by the initial strategic plan under \n                this subsection, and every 5 years thereafter, the \n                Director of NIH, in consultation with the directors of \n                the national research institutes and national centers, \n                stakeholders in the scientific field, advocates, and \n                the public at large, shall--\n                            ``(i) conduct a review of the plan, \n                        including each strategic focus area identified \n                        under paragraph (2)(B); and\n                            ``(ii) update such plan in accordance with \n                        this section.''."
}